Publications by authors named "Kim Sheva"

Claim this Profile
R
Radiation-Induced Cardiac Disease: Modern Techniques to Reduce Cardiac Toxicity.
Amichay Meirovitz, Kim Sheva

Pract Radiat Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Changes in Breast Cancer Induced by Radiation Therapy.
Kim Sheva, Sangita Roy Chowdhury, Nataly Kravchenko-Balasha, Amichay Meirovitz

Int J Radiat Oncol Biol Phys· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression Analysis of SSTR 1, 2 and 3 in Small-cell Lung Cancer Patients as Targets for Future Peptide Receptor Radionuclide Therapy.
Nitzan Sagie, Elizabeth Romanov, Yarden Kezerle, Amichay Meirovitz, Kim Sheva

Anticancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression.
Walid Shalata, Ashraf Abu Jama, Yulia Dudnik, Omar Abu Saleh, Sondos Shalata, Kim Sheva

Medicina (Kaunas)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.
Daniela Nahmias-Blank, Ofra Maimon, Amichay Meirovitz, Kim Sheva, Tamar Peretz-Yablonski

Semin Cancer Biol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma.
Walid Shalata, Rachel Steckbeck, Ilya Polishchuk, Ahron Yehonatan Cohen, Keren Rouvinov, Kim Sheva

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase.
Alexia Abecassis, Esther Hermano, Kim Sheva, Ariel M Rubinstein, Michael Elkin

Biomedicines· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience.
Walid Shalata, Jeremy Zolnoorian, Amichay Meirovitz, Kim Sheva, Ashraf Abu Jama

Life (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Heterozygosity of as a Predictive Marker for Talazoparib Response.
Avital Granit Mizrahi, Haneen Hamad, Ahinoam Gugenheim, Benjamin Nisman, Anna Kuznetz, Kim Sheva

Anticancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.
Walid Shalata, Sarah Weissmann, Sapir Itzhaki Gabay, Kim Sheva, Omar Abu Saleh

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance.
Heba Alkhatib, Ariel M Rubinstein, Swetha Vasudevan, Efrat Flashner-Abramson, Shira Stefansky, Kim Sheva

Genome Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified bi-weekly cetuximab-cisplatin and 5-FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients.
Amichay Meirovitz, Shani Bergerson, Nir Hirshoren, Jeffrey M Weinberger, Evgeniya Bersudski, Kim Sheva

Cancer Rep (Hoboken)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients.
Amichay Meirovitz, Menachem Gross, Vera Leibovici, Kim Sheva, Aharon Popovzer

Anticancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis